Tong XF - Search Results

1

EGF Suppresses the Initiation and Drives the Reversion of TGF-β1-induced Transition in Hepatic Oval Cells Showing the Plasticity of Progenitor Cells.

Wang P, Yang AT, Cong M, Liu TH, Zhang D, Huang J, Tong XF, Zhu ST, Xu Y, Tang SZ, Wang BE, Ma H, Jia JD, You H. Wang P, et al. Among authors: tong xf. J Cell Physiol. 2015 Oct;230(10):2362-70. doi: 10.1002/jcp.24962. J Cell Physiol. 2015. PMID: 25739869

2

[Does the epithelial-to-mesenchymal transition exist in liver fibrosis?].

Tong XF, Yang AT, Wang P, You H. Tong XF, et al. Zhonghua Gan Zang Bing Za Zhi. 2012 Jul;20(7):555-7. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 23071982 Review. Chinese. No abstract available.

3

Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis.

Cong M, Liu T, Wang P, Fan X, Yang A, Bai Y, Peng Z, Wu P, Tong X, Chen J, Li H, Cong R, Tang S, Wang B, Jia J, You H. Cong M, et al. Am J Pathol. 2013 May;182(5):1607-16. doi: 10.1016/j.ajpath.2013.01.036. Epub 2013 Mar 7. Am J Pathol. 2013. PMID: 23474083

4

Connective tissue growth factor induces hepatic progenitor cells to differentiate into hepatocytes.

Yang AT, Wang P, Tong XF, Cong M, Liu TH, Cong R, Wu P, Jia JD, Wang BE, You H. Yang AT, et al. Among authors: tong xf. Int J Mol Med. 2013 Jul;32(1):35-42. doi: 10.3892/ijmm.2013.1380. Epub 2013 May 13. Int J Mol Med. 2013. PMID: 23670439

5

Histological assessment based on liver biopsy: the value and challenges in NASH drug development.

Tong XF, Wang QY, Zhao XY, Sun YM, Wu XN, Yang LL, Lu ZZ, Ou XJ, Jia JD, You H. Tong XF, et al. Acta Pharmacol Sin. 2022 May;43(5):1200-1209. doi: 10.1038/s41401-022-00874-x. Epub 2022 Feb 14. Acta Pharmacol Sin. 2022. PMID: 35165400 Free PMC article. Review.

6

Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial.

Zhao J, Wang Q, Zhao X, Wu L, Li J, Zhang W, Xu S, Han C, Du Y, Tong X, Duan W, Cao D, Ren H, Zhao X, Ou X, Jia J, You H. Zhao J, et al. Chin Med. 2023 Feb 24;18(1):19. doi: 10.1186/s13020-023-00724-w. Chin Med. 2023. PMID: 36829229 Free PMC article.

7

Azonal steatosis correlates with disease severity and poor outcome of nonalcoholic fatty liver disease.

Tong XF, Zhao XY, Sun YM, Shi YW, Li M, Wu XN, Zhao JJ, Yang LL, Lu ZZ, Ou XJ, Jia JD, Wang QY, You H. Tong XF, et al. J Dig Dis. 2023 Jan;24(1):28-38. doi: 10.1111/1751-2980.13163. Epub 2023 Apr 4. J Dig Dis. 2023. PMID: 36908183

8

Fibroblast-specific adipocyte enhancer binding protein 1 is a potential pathological trigger and prognostic marker for liver fibrosis independent of etiology.

Zhang W, Li YJ, Zhang N, Chen SY, Tong XF, Wang BQ, Huang T, You H, Chen W. Zhang W, et al. Among authors: tong xf. J Dig Dis. 2023 Oct;24(10):550-561. doi: 10.1111/1751-2980.13230. Epub 2023 Nov 7. J Dig Dis. 2023. PMID: 37776122

9

The staging of nonalcoholic fatty liver disease fibrosis: A comparative study of MR elastography and the quantitative DCE-MRI exchange model.

Ren H, Yang D, Xu H, Tong X, Zhao X, Wang Q, Sun Y, Ou X, Jia J, You H, Wang Z, Yang Z. Ren H, et al. Heliyon. 2024 Jan 18;10(2):e24558. doi: 10.1016/j.heliyon.2024.e24558. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38312594 Free PMC article.

10

Intravoxel incoherent motion assessment of liver fibrosis staging in MASLD.

Ren H, Xu H, Yang D, Tong X, Zhao X, Wang Q, Sun Y, Ou X, Jia J, You H, Wang Z, Yang Z. Ren H, et al. Abdom Radiol (NY). 2024 May;49(5):1411-1418. doi: 10.1007/s00261-024-04207-w. Epub 2024 Mar 10. Abdom Radiol (NY). 2024. PMID: 38461432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters